CIDRAP newsletters options
The nation's cases are concentrated in area where vaccine uptake is low, with Florida and Texas making up one in three US cases in the past week.
Saudi Arabia reported a second MERS-CoV (Middle East respiratory syndrome coronavirus) case from Riyadh in the month of July, and, like the first case, involving a man who had contact with camels, according to notification from the country's ministry of health (MOH).
The patient is age 65, is not a health worker, and isn't thought to have contracted the virus from another sick person.
Researchers found that different age-groups had different associations with various COVID-19 symptoms, according to a Lancet Digital Health study late last week. The study was evaluating an artificial intelligence (AI) model for early COVID-19 detection (1 to 3 days of symptom onset).
Several factors, not just the more transmissible Delta variant, are fueling rise that threatens oxygen and medical supplies, especially in lower income countries.
Findings suggest that the ligering effects may be part of "long COVID" and shine a light on more research questions, such as what memory type is involved and if there are racial differences.
Breakthrough COVID-19 cases may be as infectious as those in unvaccinated people, says the CDC.
A randomized clinical trial found 7 days of antibiotics noninferior to 14 days.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Jul 29
A new report from the World Organisation for Animal Health (OIE) shows a global decline in the use of antimicrobials in animals.
US COVID-19 vaccine disparities (CVD) were linked with income, education, political views, and race, according to a study yesterday in the Proceedings of the National Academy of Sciences.
Most cases were mild to moderate, but 1 in 5 patients had long COVID symptoms.
The president also unveiled a new incentive plan and asked school districts to make more vaccine available for kids 12 and older.
Meanwhile, Africa's vaccine supply show improvements, and Delta-driven surges increase in parts of Asia and the Middle East.
Vaccine effectiveness (VE) for the Pfizer/BioNTech COVID-19 vaccine against COVID-19 was 91% up to 6 months after the second dose, according to a non–peer-reviewed study published yesterday on the preprint server medRxiv.
The CDC says it's up to state and local officials to determine appropriate mask use, based on metrics.
The studies, one on mental health in general and one on mood disorders, both found a higher death risk.
The WHO projects that, at the current pace, global cases could reach 200 million in the next 2 weeks.
COVID-19 reduced lifespan by up to 9 years in parts of the United States, per a new "mean unfulfilled lifespan" (MUL) metric, according to a study published yesterday in PLOS One.
The MUL is a new indicator of the impact of mortality shocks, such as the novel coronavirus or other natural disaster, on peoples' lifespan.
Five research institutions in France are under a 3-month moratorium on prion research after a retired lab worker who handled prions was diagnosed as having Creutzfeldt-Jakob disease (CJD), according to a report today in Science.
Also, cases are climbing steeply in Tokyo in the midst of the Summer Olympic Games.
